SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-23-000193
Filing Date
2023-11-16
Accepted
2023-11-16 16:11:27
Documents
12
Period of Report
2023-11-16
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20231116.htm   iXBRL 8-K 34258
  Complete submission text file 0001367644-23-000193.txt   166166

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20231116.xsd EX-101.SCH 1967
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20231116_lab.xml EX-101.LAB 25156
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20231116_pre.xml EX-101.PRE 13102
6 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20231116_htm.xml XML 2923
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 231414712
SIC: 2834 Pharmaceutical Preparations